Table 1

Data analysis estimation statistics

FigurePlotAnalysisControl groupTest groupControl_NTest_NEffect_sizeIs_pairedDifferenceci_widthci_lower_limitci_upper_limit
Figure 2BMultiple two groupsAnalysis #1CV/VEHCV/CNO77Mean differenceFalse–11.9785714395.00%–55.2371428633.12428571
Figure 2BMultiple two groupsAnalysis #1M4/VEHM4/CNO66Mean differenceFalse–41.9595.00%–55.33333333–26.9
Figure 2CMultiple two groupsAnalysis #2CV/VEHCV/CNO77Mean differenceFalse–2.85714285795.00%–19.5714285717.71428571
Figure 2CMultiple two groupsAnalysis #2M4/VEHM4/CNO66Mean differenceFalse–20.595.00%–35.33333333–12.33333333
Figure 2DMultiple two groupsAnalysis #3CV/VEHCV/CNO65Mean differenceFalse–3395.00%–81.6666666713.33333333
Figure 2DMultiple two groupsAnalysis #3M4/VEHM4/CNO1010Mean differenceFalse121.0595.00%31.25188.4
Figure 3ATwo groupsAnalysis #4VEHCNO1012Mean differenceFalse0.135895.00%–11.8034833314.73156667
Figure 3BPairedAnalysis #5VEHCNO77Mean differenceTrue–2.71428571495.00%–47.1428571446.14285714
Figure 3CPairedAnalysis #6VEHCNO77Mean differenceTrue10.4142857195.00%–115.8285714139.0714286
Figure 3DPairedAnalysis #7VEHCNO77Mean differenceTrue6.85714285795.00%2.28571428610.57142857
Figure 3EPairedAnalysis #8VEHCNO66Mean differenceTrue195.00%–2.1666666674
Figure 3FPairedAnalysis #9VEHCNO66Mean differenceTrue0.595.00%–0.6666666672.166666667
Figure 3GMultiple pairedAnalysis #10VEH/ActiveVEH/Inactive77Mean differenceTrue–432.285714395.00%–595–346.2857143
Figure 3GMultiple pairedAnalysis #10CNO/ActiveCNO/Inactive77Mean differenceTrue–450.142857195.00%–529.4285714–376.8571429
Figure 3HMultiple pairedAnalysis #11VEH/ActiveVEH/Inactive66Mean differenceTrue–46.6666666795.00%–56.33333333–34.5
Figure 3HMultiple pairedAnalysis #11CNO/ActiveCNO/Inactive66Mean differenceTrue–42.6666666795.00%–69.5–21.5
Figure 3IMultiple pairedAnalysis #12VEH/ActiveVEH/Inactive66Mean differenceTrue–1695.00%–25.66666667–9.833333333
Figure 3IMultiple pairedAnalysis #12CNO/ActiveCNO/Inactive66Mean differenceTrue–21.1666666795.00%–26.66666667–15.66666667
Figure 4BTwo groupsAnalysis #13VEHCNO56Mean differenceFalse–71.3333333395.00%–84.3–56.4
Figure 5CMultiple two groupsAnalysis #14VEH/SALVEH/DOI45Mean differenceFalse1.939195.00%–11.857812.1919
Figure 5CMultiple two groupsAnalysis #14CNO/SALCNO/DOI45Mean differenceFalse2.8763595.00%–7.744717.15425
Figure 5DMultiple two groupsAnalysis #15VEH/SALVEH/DOI45Mean differenceFalse–11.763595.00%–29.80415.1315
Figure 5DMultiple two groupsAnalysis #15CNO/SALCNO/DOI65Mean differenceFalse35.8333333395.00%11.4333333355.36666667
Figure 5EMultiple two groupsAnalysis #16VEH/SALVEH/DOI45Mean differenceFalse2.4595.00%–0.96.25
Figure 5EMultiple two groupsAnalysis #16CNO/SALCNO/DOI65Mean differenceFalse9.93333333395.00%–2.16666666717.56666667
Extended Data Figure 3-1Two groupsAnalysis #17VEHCNO1012Mean differenceFalse–29.9416666795.00%–99.8883333317.455
Extended Data Figure 5-1Multiple two groupsAnalysis #18VEH/SALVEH/DOI45Mean differenceFalse4.2395.00%–14.91525.525
Extended Data Figure 5-1Multiple two groupsAnalysis #18CNO/SALCNO/DOI45Mean differenceFalse1.54595.00%–28.44522.1
  • VEH, peripheral vehicle injection; CNO: peripheral CNO injection; SAL, saline microinjection through cannula; DOI, DOI microinjection through cannula; M4, hM4Di expressing mice; CV, control vector expressing mice; active, active lever presses; inactive, inactive lever presses.